The most recent diagnostic criteria for sepsis include organ failure. Microvascular endothelial injury is believed to lead to the multiple organ failure seen in sepsis, although the precise mechanism is still controversial. ARDS is the primary complication during the sequential development of multiple organ dysfunction in sepsis, and endothelial injury is deeply involved. Sugar-protein glycocalyx coats all healthy vascular endothelium, and its disruption is one factor believed to contribute to microvascular endothelial dysfunction during sepsis. The goal of this study was to observe the three-dimensional ultrastructural alterations in the pulmonary capillary endothelium, including the glycocalyx, during sepsis-induced pulmonary vasculitis.
Sepsis is an autodestructive process in which excessive pathophysiological responses to infection result in organ dysfunction. The diagnostic criteria for sepsis include organ failure caused by several factors, including blood distribution abnormalities, heart contractility disorder, vascular hyperpermeability, endothelial injury, and decreased glomerular filtration. 1 In addition, ARDS is a clinical phenotype caused by sepsis. It results from diffuse injury to cells that form the alveolar barrier, surfactant dysfunction, activation of innate immune response, and abnormal coagulation. Previous reports have suggested that degradation of endothelial glycocalyx contributes to the pathogenesis of ARDS. 2, 3 The endothelial glycocalyx functions as a gatekeeper that plays key roles in maintaining an oncotic gradient across the endothelial barrier, regulating adhesion/migration of leukocytes, and inhibiting intravascular thrombosis. [4] [5] [6] [7] In particular, the glycocalyx is an important determinant of vascular permeability. 8, 9 Its acute disruption during sepsis, as well as in chronic conditions such as diabetes and hypertension, exposes endothelial cells to blood, and vascular permeability is increased. 5, 10, 11 It has also been shown that experimental removal of the glycocalyx causes a dramatic rise in hydraulic permeability. 12 However, the relation between the structure and function of glycocalyx remains unclear. Particularly difficult to characterize and understand has been the three-dimensional structure of endothelial glycocalyx because of its fragility and instability. 13 Moreover, little is known about the morphology of lung vascular endothelial injury related to sepsis-induced pulmonary vasculitis.
The aim of this study is to clarify the three-dimensional ultrastructural alterations in the pulmonary capillary endothelium, including the glycocalyx, during sepsisinduced pulmonary vasculitis.
Methods

In Vivo Animal Studies
This study conformed to the Guide for the Care and Use of Laboratory Animals and was approved by the Institutional Animal Research Committee of Gifu University. Following starvation for 16 h, 10-week-old male mice were intraperitoneally administered lipopolysaccharide (LPS) (20 mg/kg; MilliporeSigma). The survival rate was determined 48, 72, and 96 h following LPS administration. Blood samples were collected from the ophthalmic artery of the survivors, after which the mice were killed, and lung specimens were collected.
Electron Microscopy
To detect endothelial glycocalyx with the use of electron microscopy, mice were anesthetized and perfused with a solution composed of 2% glutaraldehyde, 2% sucrose, 0.1 M sodium cacodylate buffer (pH 7.3), and 2% lanthanum nitrate through a cannula placed in the left ventricle 48 h following administration of LPS. Prior to perfusion, an incision was made in the right atrial appendage, and the neck was ligated with a silk suture. In addition, a perfusion pump was used for injection at a steady rate of 1 mL/min. The lung was then harvested and diced. Three or four pieces of approximately 1 mm 3 each were immersed in the perfusion solution for 2 h for fixation and then soaked overnight in a solution without glutaraldehyde prior to being washed in alkaline (0.03 mol/L of sodium hydroxide) sucrose (2%) solution. The specimens were then dehydrated through a graded ethanol series.
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The frozen fracture method was used to prepare samples for examination by using scanning electron microscopic imaging. Each sample was laid on an iron plate chilled with liquid nitrogen, and ethanol was sprinkled onto it. Once the ethanol was frozen, the sample was fractured using a chisel, ensuring that it was not touched directly. The samples were then incubated in tert-butyl alcohol at room temperature. After the tert-butyl alcohol had solidified, it was freeze-dried, and the specimens were examined by using scanning electron microscopic methods (S-4800; Hitachi).
To prepare samples for transmission electron microscopic (TEM) imaging, each specimen was embedded in epoxy resin. Ultrathin sections (90 nm), stained with uranyl acetate and lead citrate, were then examined by using TEM imaging (HT-7700; Hitachi).
For standard electron microscopic imaging, 2.5% glutaraldehyde in 0.1 mol/L phosphate buffer (pH 7.4) without lanthanum nitrate was used as the fixative.
In Vivo Assay of Blood Vessel Permeability
Sixteen hours prior to LPS injection, 10-week-old male mice were intraperitoneally administered a sterile solution of Evans blue in phosphate-buffered saline (Wako, 100 mg/kg) and then starved. The mice were killed 0, 1, 3, 6, 12, 24, and 48 h following administration of LPS (n ¼ 6, at each time points). Phosphate-buffered saline containing 2 mmol/L of EDTA was perfused to wash out the Evans blue solution from the vessel lumen prior to the mice being killed. Following killing of the mice, their lungs were collected, and tissue samples in tubes were dried at 65 C in an oven to eliminate variation in water content.
Then, 500 ml of formamide was added to each tube, and the samples were incubated at 60 C for an additional 24 h to extract the Evans blue from tissue. Following the Evans blue extraction, the absorbance of the solution at 610 nm was measured. The amount of extravasated Evans blue was calculated per milligram of tissue.
Quantitative Assessments of the Endothelial Glycocalyx Area
Quantitative assessments of the endothelial glycocalyx occupation area of the capillary lumen area were performed on six randomly chosen capillary vessels in TEM images by using ImageJ software. The pulmonary capillary lumen area was measured with a polygon selections tool. The threshold image of the glycocalyx inside capillaries lumen using the automated routine was settled. The automated threshold includes only the black areas that were stained by lanthanum.
Immunohistochemistry
Following de-paraffinization, 4-mm-thick sections were cut and incubated with a primary antibody against Gr-1 (ab8592; Abcam), a surface marker of activated neutrophils. A Vectastain Elite ABC system (Vector Laboratories) was then used to immunostain. Nuclei were stained with hematoxylin.
Measurement of Syndecan-1 and Thrombomodulin in the Plasma
Following LPS administration to mice, plasma concentrations of syndecan-1 and thrombomodulin were measured (n ¼ 6, at each time point) by using an ELISA kit (for syndecan-1: Diaclone, catalog number 860.090.192; for thrombomodulin: Abcam, catalog number ab209880).
Western Analysis
Total protein concentrations in tissue lysates were measured by using bicinchoninic acid protein assays. Samples of the protein (10 mg) were then separated by using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto nitrocellulose transfer membranes (MilliporeSigma). The membranes were then probed by using antibodies against syndecan-1 (Abcam, catalog number ab34164) or glyceraldehyde-3-phosphate dehydrogenase (Santa Cruz Biotechnology, catalog number sc-32233). The blots were then visualized by using chemiluminescence (ECL; GE Healthcare UK Ltd), and the signal intensity was quantified by densitometry using ImageJ as an arbitrary unit. Samples of n ¼ 6 from each group were subjected to Western blotting.
Statistical Analysis
Values are shown as means AE SE. Survival was analyzed by using the Kaplan-Meier method with the log-rank Cox-Mantel method. The significance of differences was evaluated by using two-tailed t tests. P values < .05 were considered significant.
Results
Endothelial Glycocalyx in Normal Capillaries
To confirm the surface structure of normal pulmonary capillaries, ultrastructural analysis was first performed by using scanning electron microscopic and TEM imaging without lanthanum nitrate staining (Fig 1) . Continuous pulmonary capillaries were characterized by the presence of an uninterrupted endothelium and a continuous basal lamina. Endothelial cells were recognized according to their marginal fold ( Fig 1A2) . TEM images revealed that the structure of pulmonary capillaries consists of three bound layers: vascular endothelium, basement membrane, and alveolar epithelium ( Fig 1B2) . Endothelial glycocalyx was invisible in the absence of lanthanum nitrate staining.
Lanthanum nitrate staining revealed moss-like endothelial glycocalyx covering the surface of the vascular endothelium (Figs 1A4, 1B4). To confirm that these structures were in fact endothelial glycocalyx, the backscattered electron method with scanning electron microscopic imaging was used ( Fig 1A5) . The detected backscattered high-energy electrons that rebounded from the sample surface indicated the presence of metals in the sample. Moreover, the location of backscattered electrons was consistent with the moss-like structure, indicating that it was the endothelial glycocalyx stained with lanthanum nitrate. Because the endothelial cells were coated with endothelial glycocalyx, their surface was not seen directly. The occupancy of the endothelial glycocalyx area inside the lumen area of the pulmonary capillaries was 3.7 AE 0.6%. 
Endothelial Glycocalyx During Experimental Endotoxemia
Forty-eight hours following administration of LPS, 21% of the treated mice (10 of 48) remained alive (Fig 2A) . To quantitatively analyze the glycocalyx, plasma levels of syndecan-1, a component of glycocalyx and a marker of glycocalyx injury, were measured. We found that plasma syndecan-1 levels were significantly higher in LPS-injected mice than in sham mice. The levels had significantly increased by 6 h following LPS injection and had reached a peak by 24 h. By 48 h following LPS injection, however, plasma syndecan-1 levels had returned to baseline (Fig 2B) .
To further assess for endothelial injury, plasma thrombomodulin concentrations were examined. Thrombomodulin is an integral membrane protein expressed on the surface of healthy endothelial cells and serves as a cofactor for thrombin; it is released from the endothelium under endothelial injury condition.
14 The concentration of plasma thrombomodulin levels significantly increased 92.2 AE 5.0 ng/mL 6 h following LPS injection and 134.8 AE 14.1 ng/mL 24 h following injection compared with baseline (10.8 AE 0.9 ng/mL) ( Fig 2C) .
ARDS is characterized by increased numbers of neutrophils within the lung and increased capillary permeability, leading to pulmonary edema and, as a result, to decreased pulmonary gas exchange. 15, 16 To quantitatively analyze blood vessel permeability, the extravasation of Evans blue was measured. Three hours following treatment, the amount of extravasated Evans blue was significantly higher in LPS-injected mice than in the sham mice. The level of extravasation reached a peak about 6 h following administration of LPS and then gradually declined (Fig 2C) . This finding suggests that LPS increases the permeability of pulmonary capillaries and that the endothelial injury peaks approximately 6 h following administration of LPS. Plasma syndecan-1 levels were increased beginning 6 h following LPS administration, reached a peak at 24 h following LPS administration, and then decreased. There was no significant difference between syndecan-1 levels prior to and 48 h following LPS administration. *P < .05 vs prior to LPS administration. C, Time course of the plasma thrombomodulin concentration. Plasma thrombomodulin levels were increased beginning 6 h following LPS administration, reached a peak at 24 h following LPS administration, and then decreased. *P < .05 vs prior to LPS administration. D, Extravasated Evans blue concentration, compensated by organ weight. Levels were increased beginning 3 h following LPS administration and reached a peak following 6 h. *P < .05 vs prior to LPS administration. LPS ¼ lipopolysaccharide.
Extravasated neutrophils contribute to pulmonary injury. We observed activated neutrophils binding tightly to endothelial cells and penetrating the pulmonary capillary endothelium in LPS-injected mice (Fig 3A) . The number of Gr-1-positive cells within the lung tissues was significantly increased in LPS-injected mice (179 AE 9 cells/HPF in the group 6 h after LPS administration; 35 AE 3 cells/HPF in the group 48 h after LPS administration) compared with the sham group (6 AE 1 cells/HPF in the sham group), especially 6 h following LPS administration (P < .01, groups 6 h and 48 h after LPS administration vs sham group) ( Figs 3B, 3C ).
Because syndecan-1 is released from endothelial cells into the circulation upon endothelial injury, we anticipated that its levels would be decreased within damaged lungs. Consistent with that idea, plasma syndecan-1 levels were significantly increased 12 h and 24 h following injection (6.8 AE 1.7 ng/mL and 15.9 AE 2.0 ng/mL, respectively) compared with baseline (0.9 AE 0.4 ng/mL; P ¼ .03 and .001) (Figs 3D, 3E ). 
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Examination of the pulmonary capillary wall using scanning electron microscopic images revealed that it became thicker following LPS injection as a result of elicited edematous changes ( Figs 4A1, 4A2) . Within the endothelium, numerous infiltrating neutrophils could be seen ( Figs 4B1, 4B2) , and only scanty glycocalyx was detected on the luminal surface of the capillary (Figs 4A3, 4A4) . Moreover, the glycocalyx was occasionally seen peeling away from the capillary surface to form debris. According to TEM imaging, a thickening of the alveolar septum due to enlargement of the basal membrane was noted. The endothelial cells had become edematous, and the endothelial glycocalyx was peeling off (Figs 4B3, 4B4 ).
In addition, using both scanning electron microscopic and TEM imaging without lanthanum nitrate staining, we observed spherical structures following LPS injection (Figs 5A1, 5B1). These structures were smaller in diameter than RBCs, and they had a single membrane (Figs 5A2, 5B2). Lanthanum nitrate staining revealed the presence of glycocalyx within them (Fig 5B4) .
Recovery of Endothelial Glycocalyx Following Experimental Endotoxemic Injuries
It is believed that the inflammation caused by LPS administration was restored until 48 h following LPS injection, because plasma IL-6 and syndecan-1 have already peaked at 48 h following LPS administration. Therefore, to confirm restoration of endothelial glycocalyx following LPS administration, syndecan-1 protein expression of lung was examined 48, 72, and 96 h following administration of LPS. The syndecan expression was significantly recovered at 96 h following LPS administration (Fig 6A) . The recovery of the endothelial glycocalyx structure was then also determined in scanning electron microscopic and TEM imaging (Fig 6B) .
Discussion
The present study describes the three-dimensional glycocalyx structure of pulmonary capillaries. In a previous report, the percentage of glycocalyx varied in different capillary structures. 11 The present study showed that the glycocalyx of pulmonary capillaries is at the low end of the range compared with that of the heart and kidney. 17 The glycocalyx could serve as a mechanosensor to fluid shear stress, [17] [18] [19] and fluid shear stress on endothelial cells can increase the amount of synthetic glycosaminoglycan (which is a component of endothelial glycocalyx) by cells. [20] [21] [22] The pulmonary circulation is a low-pressure system (ie, a low fluid shear stress system) compared with cardiovascular and renovascular circulation. Because the fluid share stress on the pulmonary capillary wall is lower than on capillaries of the heart and kidney, it is believed that the pulmonary endothelial glycocalyx is thinner than in the heart and kidney.
Sepsis commonly progresses to ARDS, an inflammatory lung disease with high morbidity. ARDS is precipitated by an influx of neutrophils, causing acute inflammation and resulting in interstitial edema, loss of surfactant, and diffuse alveolar damage. This scenario in turn leads to chestjournal.org reduced lung compliance and impaired gas exchange. An earlier report suggested that degradation of the endothelial glycocalyx contributes to the pathogenesis of ARDS. 2, 3 Consistent with that idea, the present threedimensional images revealed exacerbated pulmonary vascular permeability and peeling away of the endothelial glycocalyx from endothelial cells following injection of LPS. The high mortality raises concern for a survival bias in the data collected from the mice at later time points. Therefore, we also examined a lower dose sepsis model in which 10 mg/kg of LPS was injected. Forty-eight hours following LPS administration, 17 of the 20 injected mice (85%) were still alive. In this model, we confirmed endothelial glycocalyx injuries 48 h following LPS administration in scanning electron microscopic and TEM imaging (data not shown).
LPS induces release of tumor necrosis factor, which activates neutrophils and increases their expression of adhesion molecule E-selectin. The activated neutrophils then bind to injured endothelial cells and extravasate, leading to inflammation and organ dysfunction. 23 In the present study, we were able to directly visualize the extravasating neutrophils with the use of scanning electron microscopic images.
Synthesis of glycocalyx is complicated, involving multiple enzymatic pathways and factors regulating its shedding, including local pH and mechanical stimuli. 24 Syndecan-1 is the core protein in heparan sulfate proteoglycan, which comprises glycocalyx. Syndecan-1 is released from the endothelium upon injury to the glycocalyx, causing its concentration in the circulation to increase. 25 We observed that plasma syndecan-1 levels were increased and tissue syndecan-1 was decreased following LPS injection, which is consistent with earlier reports. 24, 25 However, it was unclear how the endothelial glycocalyx was injured under stressful conditions such as sepsis.
We observed numerous spherical structures within vessels following LPS administration. These structures were smaller than RBCs and had a single-membrane structure, not the double-membrane characteristic of exosomes; in addition, these spheres contained glycocalyx. Because they were even detected in the specimens without lanthanum nitrate staining, they must contain elements from endothelial cells as well as glycocalyx. This scenario suggests endothelial glycocalyx breaks off from endothelial cells together with a portion of the endothelial plasma membrane to form spherical bodies inside the capillaries. Although many of these structures were detected approximately 6 h following LPS administration, their numbers had decreased by 12 h following LPS administration. Apparently, these spherical structures exist for only a short period following endothelial injury, and their significance is not yet known. A previous report showed that the shedding of glycocalyx and release of syndecans into the circulation may serve an adaptive function by limiting the inflammatory damage through structural rearrangement of endothelial cells and the loosening of intercellular junctions. 26 These spherical structures may have something to do with the structural rearrangement of endothelial cells under septic conditions. However, additional study is needed to clarify the precise mechanism by which they are formed and their function.
The present study also showed that the endothelial glycocalyx layer returns to normal with resolution of injury. The result is that the endothelial glycocalyx is recovered in a short period of time. However, it is still unknown whether the recovery is of the endothelial cell disorder itself or a turnover of endothelial cells. Further study is therefore required.
Syndecan-1 has been used as a marker for glycocalyx injury in several clinical reports. 25, 27, 28 It was recently reported that measurement of syndecan-1 levels in patients with sepsis might be useful for identifying those at high risk of organ dysfunction and mortality as well as those who could benefit from therapies targeted at protecting or restoring the glycocalyx. 27 Therefore, it is surmised that glycocalyx injuries have a relation with human disease. Systemic inflammation such as sepsis causes endothelial glycocalyx injuries, fluid leakage from capillaries, and impairment of fluid drainage from the lungs. Fluid accumulation in the lungs and decreased surfactant production cause whole air sacs to collapse. The collapse of the air sacs and small airways interferes with the process of normal gas exchange. Therefore, if glycocalyx disruption could be prevented, ARDS might be attenuated through inhibition of these phenomena. The control of endothelial glycocalyx has the potential to mediate a positive therapeutic effect.
Conclusions
It appears endothelial glycocalyx in the lung is markedly disrupted under experimental endotoxemia conditions. This supports the notion that disruption of the glycocalyx is causally related to the microvascular endothelial dysfunction characteristic of sepsis-induced ARDS.
